Table 1.
Patient characteristic | No. of patient (%) |
---|---|
Gender | |
Male | 38 (62.3) |
Female | 23 (37.7) |
Age | |
>65 | 35 (57.38) |
<65 | 26 (42.63) |
Co-morbidities a | |
Cardiac disease | 22 (36.07) |
bRenal impairment | 23 (37.70) |
Diabetes mellitus | 16 (26.23) |
Chronic obstructive pulmonary disease | 8 (13.11) |
Autoimmune disease | 6 (9.84) |
Onset of BSI c | |
Nosocomial | 31 (50.82) |
Healthcare-associated | 22 (36.07) |
Community-acquired | 8 (13.11) |
Source of BSI | |
Unknown | 15 (24.6) |
Prosthetic device | 30 (49.18) |
Other | 16 (26.23) |
Susceptibility of infecting isolate | |
Methicillin-susceptible S. aureus | 46 (75.41) |
Methicillin-resistant S. aureus | 15 (24.59) |
Outcome of BSI | |
Uncomplicated BSI | 50 (81.96) |
Complicated BSI | 11 (18.03) |
Death | 2 (3.28) |
Type of complication | |
Infective endocarditis | 8 (13.11) |
Persistently positive blood culture | 1 (1.64) |
septic arthritis | 1 (1.64) |
Discitis | 1 (1.64) |
aMore than one co-morbidity was indentified in some patients. bOf 23 patients with renal impairment, 21 were on haemodialysis (HD), one had chronic renal failure but was not on HD and one was receiving plasmaphoresis for Waldenströms macroglobulinaemia. cOnset of BSI defined as described by Friedman et al., 2002 [8].